BRNS

Barinthus Biotherapeutics
BRNS

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $18.4M invested in Barinthus Biotherapeutics in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less funds holding in top 10

Funds holding in top 10: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

57% less capital invested

Capital invested by funds: $42.4M → $18.4M (-$24M)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$7.07K
2
+$5.19K

Top Sellers

1
-$992K
2
-$462K
3
-$341K
4
EMG
ETF Managers Group
New Jersey
-$108K
5
Millennium Management
Millennium Management
New York
-$11.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$7.87M
2
$3.34M
3
$3.12M
4
$2.82M
5
$561K
6
$357K
7
$272K
8
$48K
9
$10K
10
$5.44K
11
–
12
–
13
–
14
–